Schedule 13G ownership disclosure

KARYOPHARM THERAPEUTICS INC

Security class unavailable · CUSIP: 48576U106

Event date: 2018-01-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-18-004055
Form type
SC 13G
Filer
Karyopharm Therapeutics Inc.
CIK
CIK 1503802
Filed
Jan 26, 2018
Reporting period
Jan 16, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub